drugset / Trial / NCT06205615

Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B

NCT06205615 ↗

Phase 2 Completed 24 enrolled Bio 54, LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The goal of this clinical trial is to test if the study drug, BXP154B works to stop bleeding from a minor wound in patients that are on apixaban for anticoagulant therapy. The main questions it aims to answer are: * How long does it take to stop bleeding after BXP154B is applied to a wound? * How many people require the use of a rescue treatment to stop bleeding? * Does BXP154B reduce instances of re-bleeding after the bleeding has stopped initially? * Is BXP154B safe and well-tolerated?

Timeline

Start
2024-01-24
Primary completion
2024-03-14
Completion
2024-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject BXP154B Unknown 6 ml Topical